Licensure of a meningococcal conjugate vaccine (Menveo) and guidance for use - Advisory Committee on Immunization Practices (ACIP), 2010.

Details

• Journal Article:
  Morbidity and Mortality Weekly Report (MMWR)
• Corporate Authors:
  United States. Advisory Committee on Immunization Practices.
• Description:
  On February 19, 2010, the Food and Drug Administration (FDA) licensed a quadrivalent meningococcal conjugate vaccine, MenACWY-CRM (Menveo, Novartis Vaccines and Diagnostics). MenACWY-CRM is licensed as a single dose for use among persons aged 11-55 years. The Advisory Committee on Immunization Practices (ACIP) reviewed data from prelicensure clinical trials on the safety and immunogenicity of MenACWY-CRM. This report summarizes the approved indications for MenACWY-CRM and provides guidance from ACIP for its use. The following guidance for use of MenACWY-CRM is consistent with licensed indications and ACIP recommendations for meningococcal conjugate vaccines.
• Subjects:
  Adolescent Adult Child Child, Preschool Humans Immunization Schedule Licensure Meningococcal Infections Meningococcal Vaccines Middle Aged Neisseria Meningitidis Risk Factors Vaccines, Conjugate

  More +
• Source:
  MMWR. Morbidity and mortality weekly report. 2010; 59(9):273.
• Series:
  Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
• ISSN:
  0149-2195 (print) ; 1545-861X (digital)
• Pubmed ID:
  20224545
• Document Type:
  Text
• Genre:
  Guideline
• Place as Subject:
  United States
• Pages in Document:
  1 pdf page
• Volume:
  59
• Issue:
  9
• Collection(s):
  Guidelines and Recommendations Advisory Committee on Immunization Practices (ACIP) Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:094c55f8bbba8325793e8f511b7c1205277731f7f4862e9b2d42a93497175c879c547c58c3ead00526f9cb3bf97479c124b9ee57fda561c4a90db4c79e74a0a9
• Download URL:
  https://stacks.cdc.gov/view/cdc/7448/cdc_7448_DS1.pdf
• File Type:
  [PDF - 131.49 KB ]